Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: MHRA (Medicines & Healthcare Products Regulatory Agency)
Glyceryl trinitrate
Viatris UK Healthcare Ltd
C01DA02
Glyceryl trinitrate
15mg/24hour
Transdermal patch
Transdermal
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060100; GTIN: 5000485085542
2.75” 2.75” 8.25” 2.75” Die Line Fold Line Registration No Copy / Copy Area (0.125” L and R, 0.25” T and B) 8.25” W x 15.5” H leaflet, Front 08 APR 2008 2.5” 2.5” 15.5” 2.5” 2.5” 2.5” 2.5” 0.25” 0.25” Bar Code FPO Bar Code (BC)/BC FPO is 1” W x 0.438” H Artwork (AW) ID #/AW ID place holder area is 1” W x 0.125” H AW ID #/AW ID place holder is to be Arial or Helvetica AW ID #/AW ID place holder is to be a minimum 6pt, but must fit in AW ID area BC, AW ID #, and AW ID place holders print black AW ID place holder (X’s) is to be replaced with AW ID # BC area is 1.5” W x 0.938” H (0.25” QZ L, R; 0.188 QZ T, B) No copy other than BC, AW ID #, or place holders in BC area BC area is centered in the panel BC area top, as the BC/BC FPO reads, is flush to the first fold BC FPO XXXXXX BC FPO XXXXXX BC FPO XXXXXX 2.75” 2.75” 8.25” 2.75” Die Line Fold Line Registration No Copy / Copy Area (0.125” L and R, 0.25” T and B) 8.25” W x 15.5” H leaflet, Back 08 APR 2008 2.5” 2.5” 15.5” 2.5” 2.5” 2.5” 2.5” 0.25” 0.25” Read all of this leaflet carefully before you start using this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • In this leaflet, Minitran 5 mg, 10 mg or 15 mg transdermal patches will be called Minitran patches. What is in this leaflet: 1. What Minitran patches are and what they are used for 2. What you need to know before you use Minitran patches 3. How to use Minitran patches 4. Possible side effects 5. How to store Minitran patches 6. Contents of the pack and other information 1. What Minitran patches are Đọc toàn bộ tài liệu
OBJECT 1 MINITRAN 15 Summary of Product Characteristics Updated 15-Feb-2017 | Meda Pharmaceuticals 1. Name of the medicinal product Minitran 15 mg/ 24 h, transdermal patch 2. Qualitative and quantitative composition Minitran 15 has a surface area of 20 sq cm and contains 54 mg of glyceryl trinitrate. The average amount delivered in 24 hours is 15 mg. For the full list of excipients, see section 6.1 3. Pharmaceutical form Adhesive transdermal patch. 4. Clinical particulars 4.1 Therapeutic indications Minitran 15 is indicated for: Prophylaxis of angina pectoris either alone or in combination with other anti-anginal therapy. 4.2 Posology and method of administration Posology PROPHYLAXIS OF ANGINA PECTORIS _Adults_ The response to nitrates differs between individuals, and the minimum effective dose should be prescribed in each case. It is therefore recommended that treatment is started with one Minitran 5 patch per day, with upward dosage titration when necessary. Application can either be for a continuous period of 24 hours or intermittently, incorporating a patch free interval (usually at night). Attenuation of effect has occurred in some patients being treated with sustained release nitrate preparations. On the basis of current clinical studies it is recommended that in such cases Minitran should be applied daily with a patch free interval of 8 - 12 hours. Special populations _Elderly:_ No specific information on use in the elderly is available, but there is no evidence to suggest that an alteration in dose is required. _Paediatric population:_ The safety and efficacy of Minitran in children has yet to be established, and therefore recommendations for its use cannot be made. Method of administration Each Minitran patch is contained in a sealed sachet. The adhesive layer is covered by a protective film, which should be removed before application. The Minitran patch should be applied to a clean, dry healthy area of skin on the torso or the arms. Subsequent patches should not be applied to the same area of skin until Đọc toàn bộ tài liệu